FDA leaders are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public scrutiny.
FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public scrutiny. @arthurallen202.bsky.social has the details: kffhealthnews.org/news/article ...
-- KFF Health News (@kffhealthnews.org) Sep 12, 2025 at 11:22 AM
[image or embed]
Drudge Retort Headlines
Are We Losing Our Democracy? (70 comments)
DOD Can't Say Who it Killed in Military Strikes Against Drug Smugglers (44 comments)
More Blame GOP and Trump than Democrats for Shutdown: Poll (32 comments)
Visible from Space, Bloody Sands Expose the Slaughter of Tens of Thousands (27 comments)
Carter's Baby Clothing Brand to Slash 150 Stores Due to Tariffs (19 comments)
Mitch McConnell Slams The Heritage Foundation (17 comments)
U.S. Poised to Strike Military Targets in Venezuela (14 comments)
The Social Media Abbreviations Confusing People the Most (12 comments)
Texas Supreme Court Rules Judges Can Refuse Same Sex Marriages (12 comments)
Trump Touts Marble Lincoln Bathroom Remodel Amid Government Shutdown (11 comments)